Acuta Capital Partners as of Sept. 30, 2024
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 41 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Vaxcyte (PCVX) | 12.5 | $16M | 135k | 114.27 | |
Ocular Therapeutix (OCUL) | 8.4 | $10M | 1.2M | 8.70 | |
Tourmaline Bio (TRML) | 6.9 | $8.5M | 332k | 25.71 | |
Insmed Com Par $.01 (INSM) | 6.4 | $7.8M | 108k | 73.00 | |
Enliven Therapeutics (ELVN) | 6.1 | $7.6M | 296k | 25.54 | |
Crinetics Pharmaceuticals In (CRNX) | 5.5 | $6.7M | 132k | 51.10 | |
Arcellx Common Stock (ACLX) | 4.2 | $5.2M | 62k | 83.51 | |
Mereo Biopharma Group Spon Ads (MREO) | 4.2 | $5.2M | 1.3M | 4.11 | |
Revolution Medicines (RVMD) | 4.0 | $4.9M | 108k | 45.35 | |
Taysha Gene Therapies Com Shs (TSHA) | 3.4 | $4.3M | 2.1M | 2.01 | |
Terns Pharmaceuticals (TERN) | 3.3 | $4.1M | 487k | 8.34 | |
Kura Oncology (KURA) | 3.1 | $3.8M | 197k | 19.54 | |
Aadi Bioscience (AADI) | 3.1 | $3.8M | 1.8M | 2.06 | |
Rocket Pharmaceuticals (RCKT) | 2.8 | $3.5M | 190k | 18.47 | |
Praxis Precision Medicines I (PRAX) | 2.7 | $3.3M | 58k | 57.54 | |
Argenx Se Sponsored Adr (ARGX) | 2.6 | $3.2M | 5.9k | 542.08 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 2.5 | $3.1M | 21k | 149.31 | |
Compass Pathways Sponsored Ads (CMPS) | 2.0 | $2.4M | 387k | 6.30 | |
Mersana Therapeutics (MRSN) | 1.8 | $2.3M | 1.2M | 1.89 | |
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.5 | $1.9M | 181k | 10.45 | |
Acelyrin (SLRN) | 1.5 | $1.8M | 364k | 4.93 | |
Edgewise Therapeutics (EWTX) | 1.4 | $1.7M | 63k | 26.69 | |
Dyne Therapeutics (DYN) | 1.3 | $1.7M | 46k | 35.92 | |
Gilead Sciences (GILD) | 1.3 | $1.6M | 20k | 83.84 | |
Ultragenyx Pharmaceutical (RARE) | 1.1 | $1.4M | 25k | 55.55 | |
Trevi Therapeutics (TRVI) | 0.8 | $970k | 291k | 3.34 | |
Unicycive Therapeutics (UNCY) | 0.7 | $807k | 2.0M | 0.41 | |
Liquidia Corporation Com New (LQDA) | 0.6 | $735k | 74k | 10.00 | |
Verve Therapeutics (VERV) | 0.6 | $707k | 146k | 4.84 | |
Geron Corporation (GERN) | 0.6 | $703k | 155k | 4.54 | |
Celcuity (CELC) | 0.6 | $695k | 47k | 14.91 | |
Artiva Biotherapeutics (ARTV) | 0.6 | $680k | 44k | 15.45 | |
Tectonic Therapeutic (TECX) | 0.3 | $415k | 14k | 30.30 | |
Corbus Pharmaceuticals Holdings Com New (CRBP) | 0.3 | $382k | 19k | 20.63 | |
Rapport Therapeutics (RAPP) | 0.3 | $360k | 18k | 20.48 | |
Leap Therapeutics Com New (LPTX) | 0.3 | $310k | 121k | 2.57 | |
Eliem Therapeutics (CLYM) | 0.2 | $275k | 54k | 5.09 | |
Benitec Biopharma Com New (BNTC) | 0.2 | $274k | 30k | 9.19 | |
Travere Therapeutics (TVTX) | 0.2 | $266k | 19k | 13.99 | |
Third Harmonic Bio (THRD) | 0.2 | $210k | 16k | 13.55 | |
Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $8.9k | 91k | 0.10 |